X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with SHASUN PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB SHASUN PHARMA UNICHEM LAB/
SHASUN PHARMA
 
P/E (TTM) x 29.1 123.9 23.5% View Chart
P/BV x 3.1 8.5 35.9% View Chart
Dividend Yield % 0.6 0.2 266.1%  

Financials

 UNICHEM LAB   SHASUN PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
SHASUN PHARMA
Mar-14
UNICHEM LAB/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs33494 354.6%   
Low Rs17446 381.6%   
Sales per share (Unadj.) Rs146.9214.2 68.6%  
Earnings per share (Unadj.) Rs11.95.3 222.9%  
Cash flow per share (Unadj.) Rs16.215.8 102.3%  
Dividends per share (Unadj.) Rs2.001.00 200.0%  
Dividend yield (eoy) %0.81.4 55.0%  
Book value per share (Unadj.) Rs105.153.3 197.1%  
Shares outstanding (eoy) m90.8456.62 160.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.70.3 529.8%   
Avg P/E ratio x21.413.1 163.0%  
P/CF ratio (eoy) x15.74.4 355.1%  
Price / Book Value ratio x2.41.3 184.4%  
Dividend payout %16.818.7 89.7%   
Avg Mkt Cap Rs m23,0733,958 583.0%   
No. of employees `0005.7NA-   
Total wages/salary Rs m2,5582,164 118.2%   
Avg. sales/employee Rs Th2,352.5NM-  
Avg. wages/employee Rs Th450.9NM-  
Avg. net profit/employee Rs Th190.4NM-  
INCOME DATA
Net Sales Rs m13,34612,127 110.0%  
Other income Rs m192229 83.7%   
Total revenues Rs m13,53812,356 109.6%   
Gross profit Rs m1,6391,009 162.4%  
Depreciation Rs m390594 65.7%   
Interest Rs m29415 6.9%   
Profit before tax Rs m1,412230 614.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40 1,233.3%   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m293-73 -402.5%   
Profit after tax Rs m1,080302 357.6%  
Gross profit margin %12.38.3 147.6%  
Effective tax rate %20.7-31.7 -65.5%   
Net profit margin %8.12.5 324.9%  
BALANCE SHEET DATA
Current assets Rs m5,9796,884 86.9%   
Current liabilities Rs m2,4328,456 28.8%   
Net working cap to sales %26.6-13.0 -205.1%  
Current ratio x2.50.8 302.0%  
Inventory Days Days6362 102.3%  
Debtors Days Days60108 56.1%  
Net fixed assets Rs m6,4034,970 128.8%   
Share capital Rs m182113 160.4%   
"Free" reserves Rs m9,2932,875 323.2%   
Net worth Rs m9,5483,020 316.2%   
Long term debt Rs m2301,817 12.7%   
Total assets Rs m12,84313,347 96.2%  
Interest coverage x50.01.6 3,220.8%   
Debt to equity ratio x00.6 4.0%  
Sales to assets ratio x1.00.9 114.4%   
Return on assets %8.65.4 160.7%  
Return on equity %11.310.0 113.1%  
Return on capital %14.313.3 107.6%  
Exports to sales %29.246.4 63.0%   
Imports to sales %6.314.2 44.5%   
Exports (fob) Rs m3,9005,622 69.4%   
Imports (cif) Rs m8471,728 49.0%   
Fx inflow Rs m4,3565,843 74.6%   
Fx outflow Rs m1,1622,173 53.5%   
Net fx Rs m3,1943,669 87.0%   
CASH FLOW
From Operations Rs m1,119398 281.5%  
From Investments Rs m-853-1,635 52.2%  
From Financial Activity Rs m-3341,309 -25.5%  
Net Cashflow Rs m-6871 -95.9%  

Share Holding

Indian Promoters % 50.1 39.2 127.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 3.6 419.4%  
FIIs % 3.0 17.6 17.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 39.6 80.1%  
Shareholders   20,176 20,750 97.2%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SANOFI INDIA  TORRENT PHARMA  PLETHICO PHARMA  CIPLA  ABBOTT INDIA  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; PSU & Healthcare Stocks Top Losers(09:30 am)

Asian equities are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1.20% while the Hang Seng is up 0.61%. The Shanghai Composite is trading up by 0.45%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 20, 2018 11:57 AM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS